BioNTech SE (BNTX)

BioNTech SE Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	25,763	27,318	25,088	36,506	62,264	19,629
Market Cap Growth	-0.36%	8.89%	-31.28%	-41.37%	217.21%	156.06%
Enterprise Value	10,685	8,954	8,633	23,607	59,821	18,637
Last Close Price	106.57	113.95	105.54	150.22	255.33	80.74
PE Ratio	-	-	24.40	3.62	5.32	1055.70
Forward PE	-	-	67.81	8.27	8.07	10.17
PS Ratio	8.63	9.59	5.94	1.97	2.89	33.27
PB Ratio	1.25	1.36	1.12	1.70	4.60	11.70
P/TBV Ratio	1.39	1.45	1.19	1.72	4.68	13.22
P/FCF Ratio	-	-	4.43	2.58	71.83	-
P/OCF Ratio	-	127.04	4.23	2.52	61.54	-
EV/Sales Ratio	3.60	3.14	2.05	1.28	2.77	31.59
EV/EBITDA Ratio	-	-	7.04	1.84	3.53	-
EV/EBIT Ratio	-	-	8.04	1.85	3.54	-
EV/FCF Ratio	-	-	1.53	1.67	69.01	-
Debt / Equity Ratio	0.02	0.01	0.01	0.01	0.03	0.18
Debt / EBITDA Ratio	-	-	0.19	0.02	0.02	-
Debt / FCF Ratio	-	-	0.04	0.02	0.40	-
Asset Turnover	0.13	0.12	0.17	0.89	2.09	0.31
Inventory Turnover	1.89	1.69	1.51	6.36	10.28	1.56
Quick Ratio	9.86	7.26	9.12	7.19	4.15	2.50
Current Ratio	10.18	7.45	9.43	7.43	4.33	2.75
Return on Equity (ROE)	-3.94%	-3.36%	4.62%	59.06%	155.18%	1.63%
Return on Assets (ROA)	-3.67%	-3.53%	2.62%	38.09%	102.25%	-12.89%
Return on Capital (ROIC)	-4.05%	-4.00%	2.98%	45.89%	134.41%	-18.43%
Return on Capital Employed (ROCE)	-	-	4.60%	58.60%	120.20%	-
Earnings Yield	-3.23%	-2.52%	4.10%	27.62%	18.80%	0.10%
FCF Yield	-2.41%	-0.30%	22.56%	38.78%	1.39%	-0.50%
Buyback Yield / Dilution	0.51%	0.95%	2.84%	3.81%	-4.51%	-17.49%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q